ARRY-382   Click here for help

GtoPdb Ligand ID: 9108

Synonyms: ARRY 382 | ARRY382 | c-Fms-IN-12 | PF-07265804 | PF07265804
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: ARRY-382 is an investigational, orally administered small molecule inhibitor of the receptor tyrosine kinase, CSF1R (Fms).
The chemical structure shown here was reproduced from Offringa et al. (2022) [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 1
Rotatable bonds 10
Topological polar surface area 88.37
Molecular weight 564.68
XLogP 1.23
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CC=CC(=N1)CN2C3=C(C(=CC=C3)NC(=O)C4=CN=C5C=C(C=CN45)OCCN6CCN(C)CC6)C(=N2)C7CC7
Isomeric SMILES CN1CCN(CCOC2=CC3=NC=C(N3C=C2)C(=O)NC4=CC=CC5=C4C(=NN5CC6=NC(C)=CC=C6)C7CC7)CC1
InChI InChI=1S/C32H36N8O2/c1-22-5-3-6-24(34-22)21-40-27-8-4-7-26(30(27)31(36-40)23-9-10-23)35-32(41)28-20-33-29-19-25(11-12-39(28)29)42-18-17-38-15-13-37(2)14-16-38/h3-8,11-12,19-20,23H,9-10,13-18,21H2,1-2H3,(H,35,41)
InChI Key JUPOTOIJLKDAPF-UHFFFAOYSA-N
References
1. Bendell J et al.
A Phase 1 Study of ARRY-382, an Oral Inhibitor of Colony-stimulating Factor-1 Receptor (CSF1R), in Patients with Advanced or Metastatic Cancers.
Accessed on 14/04/2016. Modified on 14/04/2016. Arraybiopharma.com, http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf
2. Offringa R, Kötzner L, Huck B, Urbahns K. (2022)
The expanding role for small molecules in immuno-oncology.
Nat Rev Drug Discov, 21 (11): 821-840. [PMID:35982333]